Myelofibrosis other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
|||
| Line 24: | Line 24: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Revision as of 02:51, 27 November 2017
|
Myelofibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myelofibrosis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Myelofibrosis other diagnostic studies |
|
Risk calculators and risk factors for Myelofibrosis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Other diagnostic studies for myelofibrosis include JAK2 mutation analysis testing and bone scan.[1]
Other Diagnostic Studies
JAK2 Mutation Analysis Testing
- Reverse transcriptase polymerase chain reaction (RT-PCR) may be performed to observe the JAK2 mutation.
- JAK2 mutation on Val 617 Phe locus in 50%
Bone Scan
References
- ↑ 1.0 1.1 Radiographic features of primary myelofibrosis. Dr Henry Knipe and Dr Yuranga Weerakkody et al. Radiopaedia 2016. http://radiopaedia.org/articles/myelofibrosis. Accessed on March 10, 2016